MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Sex differences on dynamic functional connectivity in Parkinson’s disease and healthy controls

    M. Diez-Cirarda, I. Gabilondo, N. Ibarretxe-Bilbao, J.C Gomez-Esteban, J. Kim, O. Lucas-Jimenez, R. Del Pino, J. Peña, N. Ojeda, A. Mihaescu, M. Valli, M.A Acera, A. Cabrera, M.A Gomez-Beldarrain, A.P Strafella (Toronto, ON, Canada)

    Objective: The main objective was to evaluate the influence of sex in time-varying functional connectivity (FC) characteristics in Parkinson’s disease (PD) patients and healthy adults…
  • MDS Virtual Congress 2020

    Temporal properties of resting-state functional MRI are associated with ON/OFF levodopa MDS-UPDRS III scores in patients with Parkinson’s disease

    M. Morrison, A. Lee, S. Wang, A. Martin, I. Bledsoe, J. Ostrem, P. Larson, P. Starr, D. Wang (San Francisco, CA, USA)

    Objective: To explore the relationship between temporal resting-state functional magnetic resonance imaging (fMRI) properties and ON/OFF Levodopa motor performance scores in patients with Parkinson's disease…
  • MDS Virtual Congress 2020

    Identifying neural signatures of Parkinson’s disease that predict decline in gait and postural control

    H. Sigurdsson, A. Yarnall, B. Galna, S. Lord, L. Alcock, R. Morris, R. Lawson, S. Colloby, M. Firbank, N. Pavese, D. Brooks, J. O'brien, D. Burn, L. Rochester (Newcastle upon Tyne, United Kingdom)

    Objective: To identify Parkinson’s disease [PD] specific patterns in the brain using a multi-modal neuroimaging design and use these to predict gait decline. Background: Gait…
  • MDS Virtual Congress 2020

    Visual Motion Perception and Metacognition in Parkinson’s disease

    O. Halperin, R. Karni, S. Israeli-Korn, S. Hassin-Baer, A. Zaidel (Ramat Gan, Israel)

    Objective: To investigate visual motion perception as a potential contributor to impaired visual self-motion perception in PD. To measured metacognitive ability and bias in PD…
  • MDS Virtual Congress 2020

    Impact of Chronotypes and melatonin levels on sleep disorders in patients with Parkinson’s disease

    R. Borgohain, M. Voodi, R. Kandadai, S. Meka, T. Syed, S. Turaga (Hyderabad, India)

    Objective: To investigate the sleep problems and circadian rhythm abnormalities in PD patients using sleep evaluation scale – Parkinsons disease sleep scale (PDSS) for mild…
  • MDS Virtual Congress 2020

    Higher adherence to MIND diet associated with later onset of Parkinson’s disease

    A. Metcalfe-Roach, M. Cirstea, A. Yu, E. Golz, K. Sundvick, D. Kliger, B. Finlay, S. Appel-Cresswell (Vancouver, BC, Canada)

    Objective: This study evaluated the impact of MIND diet adherence on Parkinson’s disease (PD) onset and related symptoms. Background: PD is a common neurodegenerative disease…
  • MDS Virtual Congress 2020

    Sleep disturbances in Vascular Parkinsonism (VP) and Parkinson’s Disease (PD) patients in early stages

    R. Raimundo, M. Mendes, R. Jesus, C. Azoia, A. Marques, A. Almeida, A. Velon (Vila Real, Portugal)

    Objective: Compare sleep disturbances between VP and PD patients. Background: Sleep disorders in PD patients are well recognized, ranging from nocturnal symptoms such as insomnia,…
  • MDS Virtual Congress 2020

    A Parkinson’s disease (PD) case with underlying cerebral small vessel disease (CSVD)

    L.X Cao, W. Dong, Y. Li, G. Du, J.H Yin, Q. Yang, Y.Q Zhang, B. Chen, Y. Huang (Beijing, China)

    Objective: Emphasis of CSVD in PD through clinical-pathological correlation study. Background: PD affects 1.7%, while CSVD affects about 45% [1], of the population aged over…
  • MDS Virtual Congress 2020

    Increased risk of Parkinson’s disease in patients with schizophrenia spectrum disorders

    T. Kuusimäki, H. Al-Abdulrasul, S. Kurki, J. Hietala, S. Hartikainen, M. Koponen, A. Tolppanen, V. Kaasinen (Turku, Finland)

    Objective: To investigate the coincidence of Parkinson’s disease (PD) and schizophrenia spectrum disorders (SCD). Background: PD is characterized by a progressive loss of mesostriatal dopamine…
  • MDS Virtual Congress 2020

    In vivo imaging of presynaptic terminal loss in early Parkinson’s disease

    A. Delva, D. Van Weehaeghe, M. Koole, K. Van Laere, W. Vandenberghe (Leuven, Belgium)

    Objective: To determine the magnitude and anatomical extent of presynaptic terminal damage in early Parkinson’s disease (PD) in vivo, we performed a PET study with…
  • « Previous Page
  • 1
  • …
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley